Brief: Surface Oncology- As Of March 31, 2020, Cash, Cash Equivalents And Marketable Securities Were $90.1 Mln
12/05/2020 11:26
May 12 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY INC - AS OF MARCH 31, 2020, CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES WERE $90.1 MILLION
* SURFACE ONCOLOGY INC - REVENUE RECOGNIZED IN THREE MONTHS
ENDED
MARCH 31, 2020 WAS $38.6 MILLION, COMPARED TO $14.4 MILLION
* SURFACE ONCOLOGY INC - CONTINUES TO PROJECT THAT CURRENT
CASH
AND CASH EQUIVALENTS ARE SUFFICIENT TO FUND COMPANY INTO 2022
* SURFACE ONCOLOGY INC QTRLY EARNINGS PER SHARE $0.74
Source text: https://bit.ly/3dDP7OB
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing